Oncogene - Table of Contents alert Volume 30 Issue 39

TABLE OF CONTENTS Volume 30, Issue 39 (September 2011) In this issue Commentary Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Have you seen this recent article published in Cancer Gene Therapy Enhanced specificity of HPV16 E6E7 siRNA by RNA-DNA chimera modification FREE K Yamato, N Egawa, S Endo, K Ui-Tei, T Yamada, K Saigo, I Hyodo, T Kiyono and I Nakagawa doi:10.1038/cgt.2011.28   Commentary Top Drosophila in cancer research: to boldly go where no one has gone before G Halder and G B Mills Oncogene 2011 30: 4063-4066; advance online publication, April 18, 2011; 10.1038/onc.2011.128 Abstract | Full Text Original Articles Top Loss of PI3K blocks cell-cycle progression in a Drosophila tumor model M Willecke, J Toggweiler and K Basler Oncogene 2011 30: 4067-4074; advance online publication, April 25, 2011; 10.1038/onc.2011.125 Abstract | Full Text Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells F Xing, H Okuda, M Watabe, A Kobayashi, S K Pai, W Liu, P R Pandey, K Fukuda, S Hirota, T Sugai, G Wakabayshi, K Koeda, M Kashiwaba, K Suzuki, T Chiba, M Endo, Y-Y Mo and K Watabe Oncogene 2011 30: 4075-4086; advance online publication, April 18, 2011; 10.1038/onc.2011.122 Abstract | Full Text β1 integrin controls EGFR signaling and tumorigenic properties of lung cancer cells V Morello, S Cabodi, S Sigismund, M P Camacho-Leal, D Repetto, M Volante, M Papotti, E Turco and P Defilippi Oncogene 2011 30: 4087-4096; advance online publication, April 11, 2011; 10.1038/onc.2011.107 Abstract | Full Text Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification J Tanizaki, I Okamoto, S Fumita, W Okamoto, K Nishio and K Nakagawa Oncogene 2011 30: 4097-4106; advance online publication, April 18, 2011; 10.1038/onc.2011.111 Abstract | Full Text C10ORF97 is a novel tumor-suppressor gene of non-small-cell lung cancer and a functional variant of this gene increases the risk of non-small-cell lung cancer Y Shi, J Chen, Z Li, Z Zhang, H Yu, K Sun, X Wang, X Song, Y Wang, Y Zhen, T Yang, K Lou, Y Zhang, G Zhang, Y Hu, J Ji and R Hui Oncogene 2011 30: 4107-4117; advance online publication, April 18, 2011; 10.1038/onc.2011.116 Abstract | Full Text MEK–ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes S Fujii, K Tokita, N Wada, K Ito, C Yamauchi, Y Ito and A Ochiai Oncogene 2011 30: 4118-4128; advance online publication, April 18, 2011; 10.1038/onc.2011.118 Abstract | Full Text Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression C Giordano, S Catalano, S Panza, D Vizza, I Barone, D Bonofiglio, L Gelsomino, P Rizza, S A W Fuqua and S Andò Oncogene 2011 30: 4129-4140; advance online publication, April 18, 2011; 10.1038/onc.2011.124 Abstract | Full Text Advertisement Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function. Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper.   Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2011 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.